Massachusetts Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Healthcare Journal.

Press releases published on October 13, 2026

Oct. 13, 2026

Stepes Expands AI-Enabled Legal Translation Services for Global Law Firms and Corporate Legal Teams

Indeterminate EIN Presswire

Oct. 13, 2026

zakipoint Health Names Fred Karutz Interim Executive Vice President, Marketing and Business Development

Indeterminate EIN Presswire

Oct. 13, 2026

Contracts 365 Announces Gold Sponsorship of Microsoft CollabDays New England 2026

Indeterminate EIN Presswire

Oct. 13, 2026

Givzey | Version2.ai Releases Cutting Edge Autonomous AI Model Built for Donor Retention

Indeterminate EIN Presswire

Oct. 13, 2026

Ten Swimmers Going Deaf and Blind Take on Alcatraz to Accelerate Usher Syndrome Research

Indeterminate EIN Presswire

Oct. 13, 2026

Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE® (setmelanotide) in Japan for Patients with Acquired Hypothalamic Obesity

Indeterminate GlobeNewswire

Oct. 13, 2026

Orum Therapeutics Doses First Patient in Phase 1 Trial of ORM-1153, a CD123-GSPT1 Degrader-Antibody Conjugate

Indeterminate GlobeNewswire

Oct. 13, 2026

Innohealth 2026 Brings Ohio's Life Sciences Leaders Together on the Talent, Research and Capital That Will Drive the Next Decade of Growth

Indeterminate GlobeNewswire

Oct. 13, 2026

TRexBio Announces Closing of Initial Public Offering

Indeterminate GlobeNewswire

Oct. 13, 2026

Charli XCX Headlines MISTR’s Star-Studded National PrEP Day Celebration

Indeterminate GlobeNewswire

Oct. 13, 2026

Zealand Pharma and Generate Biomedicines Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases

Indeterminate GlobeNewswire

Oct. 13, 2026

Generate Biomedicines and Zealand Pharma Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases

Indeterminate GlobeNewswire

Oct. 13, 2026

Biomea Fusion Announces Phase 1 Results for BMF-650, its Investigational Next-Generation Oral Small Molecule GLP-1 Receptor Agonist

Indeterminate GlobeNewswire

Oct. 13, 2026

Agomab Announces First Patient Dosed in Global NOV-ERA Phase 2b Study of Ontunisertib in Fibrostenosing Crohn's Disease

Indeterminate GlobeNewswire

Oct. 13, 2026

CapsoVision to Present at the 20th Annual LD Micro Main Event

Indeterminate GlobeNewswire

Oct. 13, 2026

Rani Therapeutics to Participate in the Chardan Healthcare Conference

Indeterminate GlobeNewswire

Oct. 13, 2026

OrthoPediatrics Corp. to Report Third Quarter Financial Results on October 27, 2026

Indeterminate GlobeNewswire

Oct. 13, 2026

Acquisition of Own Shares

Indeterminate GlobeNewswire

Oct. 13, 2026

Inkoop van eigen aandelen

Indeterminate GlobeNewswire

Oct. 13, 2026

Sangamo Therapeutics Launches Auction Process for Clinical-Stage Chronic Neuropathic Pain Program

Indeterminate GlobeNewswire